How should we think about these radical technologies? Too often our social reactions to new technologies occur only in hindsight, after a technology has penetrated the marketplace. However, recent experience teaches that much may be gained by practising forethought and foresight. Emerging Technologies addresses the ethical, legal, and social dimensions of emerging technologies and assesses their social and policy implications. Contributors examine the development, impact, and governance of new technologies emerging from a variety of fields, including biotechnology, genetics, stem cell research, pharmacology, and nanotechnology.
Authors
- Bibliography, etc. Note
- Includes bibliographical references and index
- Control Number Identifier
- CaOOCEL
- Dewey Decimal Classification Number
- 303.48/3
- Dewey Decimal Edition Number
- 22
- General Note
- Issued as part of the desLibris books collection
- ISBN
- 9780774815505 9780774815482
- LCCN
- T14.5
- LCCN Item number
- E445 2009eb
- Modifying agency
- CaBNVSL
- Original cataloging agency
- CaOONL
- Physical Description | Extent
- 1 electronic text (vii, 343 p.)
- Published in
- Canada
- Publisher or Distributor Number
- CaOOCEL
- Rights
- Access restricted to authorized users and institutions
- System Control Number
- (CaBNVSL)slc00223505 (OCoLC)503070617 (CaOOCEL)422888
- System Details Note
- Mode of access: World Wide Web
- Transcribing agency
- CaOONL
Table of Contents
- Contents 6
- Acknowledgments 10
- Abbreviations 12
- Introduction: Making Sense of Emerging Technologies 16
- Part 1: Hindsight Learnings 24
- 1 GM Foods in Hindsight 26
- 2 Patentable Subject Matter: Who Owns What Knowledge? 46
- 3 Patents in the Public Sphere: Public Perceptions and Biotechnology Patents 64
- Part 2: Foresight Applications 78
- (Transgenic) Animal Farm 80
- 4 Of Biotechnology and Blind Chickens 82
- 5 Transgenic Salmon: Regulatory Oversight of an Anticipated Technology 94
- Fields of Pharmas: Plant Molecular Farming 112
- 6 The Emerging Technology of Plant Molecular Farming 114
- 7 Policy and Regulatory Challenges for Plant-Made Pharmaceuticals in the United States 133
- 8 Forestalling Liabilities? Stakeholder Participation and Regulatory Development 151
- In the Stem Cell Fields 172
- 9 When Human Dignity Is Not Enough: Embryonic Stem Cell Research and Human Cloning in Canada 174
- Drugs—Up Close and Personal: Engaging Pharmacogenomics 196
- 10 Banking on Trust: Issues of Informed Consent in Pharmacogenetic Research 198
- 11 Pharmacogenomic Promises: Reflections on Semantics, Genohype, and Global Justice 216
- 12 Envisioning Race and Medicine: BiDil and the Insufficient Match between Social Groups and Genotypes 234
- Is Small Really Beautiful? Does Size Matter? Nanotechnologies 252
- 13 Nanotechnology and Human Imagination 254
- 14 Nanotechnology: The Policy Challenges 265
- Part 3: Governance Challenges and Emerging Technologies 286
- 15 Technology, Democracy, and Ethics: Democratic Deficit and the Ethics of Public Engagement 288
- 16 Impact Assessments and Emerging Technologies: From Precaution to “Smart Regulation”? 302
- 17 Technology Ownership and Governance: An Alternative View of IPRs 320
- Conclusion: Reflections on Emerging Technologies 340
- List of Contributors 348
- Index 352
- A 352
- B 352
- C 352
- D 353
- E 353
- G 353
- H 353
- I 353
- K 354
- M 354
- N 354
- O 354
- P 354
- R 355
- S 355
- T 356
- U 356
- V 356
- W 356
- X 356
